Webinar
Wound

Navigating the LCD Update and Medicare Audits for Skin Substitutes

Understanding Coverage, Clinical Evidence, and Audit Preparedness in Skin Substitute Treatments

As Medicare prepares to implement the proposed Local Coverage Determination (LCD) for Diabetic Foot Ulcers (DFUs) and Venous Leg Ulcers (VLUs), healthcare providers face increased scrutiny through intensified audit activities—including UPIC, RAC, and TPE audits. These audits are placing heightened emphasis on clinical documentation and the medical necessity of skin substitute products.

Speaker: Jeffrey Lehrman DPM FASPS MAPWCA CPC
Host: Gunnar Johannsson MD

Join us for an essential webinar designed to equip providers with clarity on:

What the Proposed LCD Means for Providers
Coverage Criteria: DFUs and VLUs versus other wound types
Clinical Evidence: Why certain products, like Kerecis, were included
Effective Date: When changes will come into effect, and implications if the LCD doesn’t go forward

Understanding Medicare Audits
Types of Audits: What differentiates UPIC, RAC, and TPE audits?
Audit Triggers: Common reasons audits are initiated, particularly around medical necessity and documentation

Preparing for and Navigating Audits
Compliance Preparation: Knowing and following the rules proactively, before an audit is initiated
Documentation Best Practices: Implementing compliant record-keeping before receiving any audit notice
Legal Implications: Understanding audits as legal processes between providers and payers
Critical Timelines: What documentation changes can be made once records are requested

Protecting Your Practice
Administrative Defense Coverage: What is it, and why it’s essential
Activation and Engagement: Steps to promptly activate and leverage your administrative defense coverage
Contact Guidance: Knowing whom to contact (and whom not to contact) when an audit is initiated

Don’t face policy changes unprepared.
Join us and ensure your practice remains compliant, confident, and protected amidst these significant changes in wound care reimbursement and Medicare audits.

 

Date & Time

April 15, 2025
5:00 pm
EST
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding field of cellular therapy.
Kerecis is part of Coloplast, the leading global supplier of intimate healthcare products.